Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density‐dependent in HepG2 cells
- 11 December 2006
- journal article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 210 (3), 766-773
- https://doi.org/10.1002/jcp.20891
Abstract
Hepatocyte growth factor (HGF) is a potent hepatocyte mitogen but its effect in liver cancer is conflicting. Methionine adenosyltransferase (MAT) is an essential enzyme encoded by two genes (MAT1A and MAT2A), while a third gene (MAT2β) encodes for a subunit that regulates the MAT2A‐encoded isoenzyme. MAT1A is silenced while MAT2A and MAT2β are induced in hepatocellular carcinoma (HCC). The current work examined expression of HGF/c‐met in HCC and whether HGF regulates MAT genes and growth in HepG2 cells. We found the mRNA levels of HGF and c‐met are markedly increased in HCC. To study the influence of cell density, HepG2 cells were plated under high‐density (HD) or low‐density (LD) and treated with HGF (10 ng/ml). Cell density had a dramatic effect on MAT1A expression, being nearly undetectable at LD to a ninefold induction under HD. Cell density also determined the effect of HGF. At HD, HGF increased the mRNA levels of p21 and p27, while lowering the levels of MAT genes, cyclin A, and c‐met. At LD, HGF increased the mRNA levels of cyclin A, MAT2A, MAT2β, and c‐met. Consistently, HGF inhibits growth under HD but stimulates growth under LD. HGF induced sustained high ERK activation under HD as compared to LD. In summary, HGF induces genes favoring growth and is mitogenic when HepG2 cells are plated under LD; however, the opposite occurs under HD. This involves cell density‐dependent differences in HGF‐induced ERK activation. This may explain why HGF is mitogenic only when there is loss of cell‐cell contact in vivo. J. Cell. Physiol. 210: 766–773, 2007.Keywords
This publication has 33 references indexed in Scilit:
- Hepatocyte Growth Factor Induces Redistribution of p21CIP1 and p27KIP1 through ERK-dependent p16INK4a Up-regulation, Leading to Cell Cycle Arrest at G1 in HepG2 Hepatoma CellsJournal of Biological Chemistry, 2005
- Involvement of Down-Regulation of Cdk2 Activity in Hepatocyte Growth Factor-Induced Cell Cycle Arrest at G1 in the Human Hepatocellular Carcinoma Cell Line HepG2The Journal of Biochemistry, 2004
- SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cellsJournal of Hepatology, 2004
- Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulationHepatology, 2002
- High Intensity ERK Signal Mediates Hepatocyte Growth Factor-induced Proliferation Inhibition of the Human Hepatocellular Carcinoma Cell Line HepG2Journal of Biological Chemistry, 2001
- Invasiveness of Hepatocellular Carcinoma Cell Lines: Contribution of Hepatocyte Growth Factor, c-met, and Transcription Factor Ets-1Biochemical and Biophysical Research Communications, 2001
- Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cellsJournal of Cellular Physiology, 2001
- Hepatocyte Growth Factor Enhancement of Preneoplastic Hepatic Foci Development in Rats Treated with Diethylnitrosamine and N‐Ethyl‐N‐hydroxyethylnitrosamineJapanese Journal of Cancer Research, 1995
- Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamineCarcinogenesis: Integrative Cancer Research, 1995
- Cell-density dependent expression of the c-myc gene in primary cultured rat hepatocytesBiochemical and Biophysical Research Communications, 1991